Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-04-26

FDA Approved: TRACLEER — Supplemental Application (Actelion Pharmaceuticals US, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TRACLEER (bosentan) from Actelion Pharmaceuticals US, Inc., resulting in an updated labeling as part of the supp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRACLEER (bosentan)

Snippet

SUPPL AP for TRACLEER (BOSENTAN)